Drugs for Non-small Cell Lung Cancer Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)
SKU ID : 99ST-18243185 | Publishing Date : 10-May-2021 | No. of pages : 152
Detailed TOC of Drugs for Non-small Cell Lung Cancer Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)
TABLE OF CONTENTS1 INDUSTRY OVERVIEW
1.1 Drugs for Non-small Cell Lung Cancer Industry
1.1.1 Drugs for Non-small Cell Lung Cancer Overview
1.1.2 Terminology Definition in the Report
1.1.2.1 Capacity
1.1.2.2 Sales Volume
1.1.2.3 Sales Revenue
1.1.2.4 Ex-factory Price & Sales Price
1.1.2.5 Cost
1.1.2.6 Gross Margin
1.2 Products & Services Overview Scope
1.3 Drugs for Non-small Cell Lung Cancer in the Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview
2 UPSTREAM & MANUFACTURING
2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity Overview
2.5 Production Distribution by Geography
2.5.1 Production in Major Regions / Countries
2.5.2 Trade Flow Overview
3 PRODUCT SEGMENT
3.1 Product Segmentation Market (2017 to 2021E)
3.1.1 Radiofrequency Ablation (RFA) Market
3.1.2 Radiation Therapy Market
3.1.3 Chemotherapy Market
3.1.4 Targeted Therapies Market
3.1.5 Immunotherapy Market
3.2 Market Status
4 APPLICATION / END-USE SEGMENT
4.1 Application Segmentation Market (2016 to 2021E)
4.1.1 Hospital Market
4.1.2 Clinic Market
4.1.3 Others Market
4.2 Market Status
5 NORTH AMERICA
5.1 North America Market Growth
5.2 North America Market by Countries
5.3 Major Countries Market Growth
5.3.1 United States Market Size and Growth (2016-2021E)
5.3.2 Canada Market Size and Growth (2016-2021E)
5.3.3 Mexico Market Size and Growth (2016-2021E)
6 EUROPE
6.1 Europe Market Growth
6.2 Europe Market by Countries
6.3 Major Countries Market Growth
6.3.1 Germany Market Size and Growth (2016-2021E)
6.3.2 UK Market Size and Growth (2016-2021E)
6.3.3 France Market Size and Growth (2016-2021E)
6.3.4 Russia Market Size and Growth (2016-2021E)
6.3.5 Italy Market Size and Growth (2016-2021E)
6.3.6 Rest of Europe Market Size and Growth (2016-2021E)
7 ASIA-PACIFIC
7.1 ASIA-PACIFIC Market Growth
7.2 ASIA-PACIFIC Market by Countries
7.3 Major Countries Market Growth
7.3.1 China Market Size and Growth (2016-2021E)
7.3.2 India Market Size and Growth (2016-2021E)
7.3.3 Japan Market Size and Growth (2016-2021E)
7.3.4 South Korea Market Size and Growth (2016-2021E)
7.3.5 Southeast Asia Market Size and Growth (2016-2021E)
7.3.6 Australia Market Size and Growth (2016-2021E)
7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E)
8 SOUTH AMERICA
8.1 South America Market Growth
8.2 South America Market by Countries
8.3 Major Countries Market Growth
8.3.1 Brazil Market Size and Growth (2016-2021E)
8.3.2 Argentina Market Size and Growth (2016-2021E)
8.3.3 Rest of South America Market Size and Growth (2016-2021E)
9 MIDDLE EAST & AFRICA
9.1 Middle East and Africa Market Growth
9.2 Middle East and Africa Market by Countries
9.3 Major Countries Market Growth
9.3.1 GCC Market Size and Growth (2016-2021E)
9.3.2 North Africa Market Size and Growth (2016-2021E)
9.3.3 South Africa Market Size and Growth (2016-2021E)
9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E)
10 MARKET FORECAST
10.1 Global Market Forecast Overview
10.2 Global Market Forecast by Type
10.3 Global Market Forecast by Application / End-Use
10.4 Global Market Forecast by Region
11 COMPETITION OF MAJOR PLAYERS
11.1 Bristol-Myers Squibb (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.1.1 Bristol-Myers Squibb Profile
11.1.2 Bristol-Myers Squibb Products & Services Overview
11.1.3 Bristol-Myers Squibb Main Business
11.1.4 Bristol-Myers Squibb Business Operation
11.2 GlaxoSmithKline (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.2.1 GlaxoSmithKline Profile
11.2.2 GlaxoSmithKline Products & Services
11.2.3 GlaxoSmithKline Main Business
11.2.4 GlaxoSmithKline Business Operation
11.3 Menarini (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.3.1 Menarini Profile
11.3.2 Menarini Products & Services
11.3.3 Menarini Main Business
11.3.4 Menarini Business Operation
11.4 Sanofi (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.4.1 Sanofi Profile
11.4.2 Sanofi Products & Services
11.4.3 Sanofi Main Business
11.4.4 Sanofi Business Operation
11.5 Ziopharm Oncology (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.5.1 Ziopharm Oncology Profile
11.5.2 Ziopharm Oncology Products & Services
11.5.3 Ziopharm Oncology Main Business
11.5.4 Ziopharm Oncology Business Operation
11.6 Alchemia (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.6.1 Alchemia Profile
11.6.2 Alchemia Products & Services
11.6.3 Alchemia Main Business
11.6.4 Alchemia Business Operation
11.7 Amgen (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.7.1 Amgen Profile
11.7.2 Amgen Products & Services
11.7.3 Amgen Main Business
11.7.4 Amgen Business Operation
11.8 Apotex (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.8.1 Apotex Profile
11.8.2 Apotex Products & Services
11.8.3 Apotex Main Business
11.8.4 Apotex Business Operation
11.9 BioMarin Pharmaceutical (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.9.1 BioMarin Pharmaceutical Profile
11.9.2 BioMarin Pharmaceutical Products & Services
11.9.3 BioMarin Pharmaceutical Main Business
11.9.4 BioMarin Pharmaceutical Business Operation
11.10 CellAct Pharma (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.10.1 CellAct Pharma Profile
11.10.2 CellAct Pharma Products & Services
11.10.3 CellAct Pharma Main Business
11.10.4 CellAct Pharma Business Operation
11.11 Cerulean Pharma (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.11.1 Cerulean Pharma Profile
11.11.2 Cerulean Pharma Products & Services
11.11.3 Cerulean Pharma Main Business
11.11.4 Cerulean Pharma Business Operation
11.12 Cipla (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.12.1 Cipla Profile
11.12.2 Cipla Products & Services
11.12.3 Cipla Main Business
11.12.4 Cipla Business Operation
11.13 Cornerstone Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.13.1 Cornerstone Pharmaceuticals Profile
11.13.2 Cornerstone Pharmaceuticals Products & Services
11.13.3 Cornerstone Pharmaceuticals Main Business
11.13.4 Cornerstone Pharmaceuticals Business Operation
11.14 Curis (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.14.1 Curis Profile
11.14.2 Curis Products & Services
11.14.3 Curis Main Business
11.14.4 Curis Business Operation
11.15 CytRx (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.15.1 CytRx Profile
11.15.2 CytRx Products & Services
11.15.3 CytRx Main Business
11.15.4 CytRx Business Operation
11.16 Eli Lilly (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.16.1 Eli Lilly Profile
11.16.2 Eli Lilly Products & Services
11.16.3 Eli Lilly Main Business
11.16.4 Eli Lilly Business Operation
11.17 Exelixis (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.17.1 Exelixis Profile
11.17.2 Exelixis Products & Services
11.17.3 Exelixis Main Business
11.17.4 Exelixis Business Operation
11.18 Fresenius Kabi (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.18.1 Fresenius Kabi Profile
11.18.2 Fresenius Kabi Products & Services
11.18.3 Fresenius Kabi Main Business
11.18.4 Fresenius Kabi Business Operation
11.19 Genentech (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.19.1 Genentech Profile
11.19.2 Genentech Products & Services
11.19.3 Genentech Main Business
11.19.4 Genentech Business Operation
11.20 Hikma Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.20.1 Hikma Pharmaceuticals Profile
11.20.2 Hikma Pharmaceuticals Products & Services
11.20.3 Hikma Pharmaceuticals Main Business
11.20.4 Hikma Pharmaceuticals Business Operation
11.21 Hospira (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.21.1 Hospira Profile
11.21.2 Hospira Products & Services
11.21.3 Hospira Main Business
11.21.4 Hospira Business Operation
11.22 Intas Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.22.1 Intas Pharmaceuticals Profile
11.22.2 Intas Pharmaceuticals Products & Services
11.22.3 Intas Pharmaceuticals Main Business
11.22.4 Intas Pharmaceuticals Business Operation
11.23 Karyopharm Therapeutics (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.23.1 Karyopharm Therapeutics Profile
11.23.2 Karyopharm Therapeutics Products & Services
11.23.3 Karyopharm Therapeutics Main Business
11.23.4 Karyopharm Therapeutics Business Operation
11.24 Kyowa Hakko Kirin (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.24.1 Kyowa Hakko Kirin Profile
11.24.2 Kyowa Hakko Kirin Products & Services
11.24.3 Kyowa Hakko Kirin Main Business
11.24.4 Kyowa Hakko Kirin Business Operation
11.25 Ligand Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.)
11.25.1 Ligand Pharmaceuticals Profile
11.25.2 Ligand Pharmaceuticals Products & Services
11.25.3 Ligand Pharmaceuticals Main Business
11.25.4 Ligand Pharmaceuticals Business Operation
12 COMPANY COMPETITION
12.1 Global Sales by Company
12.1.1 Global Sales by Company
12.1.2 Global Sales Share by Company
12.2 Price & Gross Margin
12.3 Landscape of Major Companies in the Market
12.3.1 Major Companies Product Type List
12.3.1 Manufacturing Regions and Headquarters of Major Companies
12.3.1 Mergers & Acquisitions
12.4 Competitive Environment for New Entrants
12.4.1 Michael Porter's Five Forces Model
12.4.2 SWOT
13 ENVIRONMENT OVERVIEW
13.1 Impact of COVID-19
13.2 Geopolitics Overview
13.3 Economic Overview of Major Countries
14 RESEARCH CONCLUSION
List of Figures, Tables and Charts Available in Drugs for Non-small Cell Lung Cancer Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)
LIST OF TABLETABLE ~ Drugs for Non-small Cell Lung Cancer Industry Dynamics & Regulations List
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E
TABLE ~ Radiofrequency Ablation (RFA) Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Radiofrequency Ablation (RFA) Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Radiation Therapy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Radiation Therapy Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Chemotherapy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Chemotherapy Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Targeted Therapies Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Targeted Therapies Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Immunotherapy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Immunotherapy Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in Volume
TABLE ~ Hospital Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Hospital Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Clinic Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Clinic Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Market Size by Type, 2016-2021E, in Volume
TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million
TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume
TABLE ~ North America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume
TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million
TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume
TABLE ~ Europe Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume
TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million
TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume
TABLE ~ ASIA-PACIFIC Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume
TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million
TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume
TABLE ~ South America Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume
TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in USD Million
TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in USD Million
TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales by Countries 2016-2021E, in Volume
TABLE ~ Middle East and Africa Drugs for Non-small Cell Lung Cancer Sales Share by Countries 2016-2021E, in Volume
TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Type 2022F-2026F, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Type 2022F-2026F, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Type 2022F-2026F, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Type 2022F-2026F, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Application / End-Use 2022F-2026F, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Application / End-Use 2022F-2026F, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Region 2022F-2026F, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Region 2022F-2026F, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Forecast by Region 2022F-2026F, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share Forecast by Region 2022F-2026F, in Volume
TABLE ~ Bristol-Myers Squibb Overview List
TABLE ~ Products & Services List of Bristol-Myers Squibb
TABLE ~ Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ GlaxoSmithKline Overview List
TABLE ~ Products & Services List of GlaxoSmithKline
TABLE ~ Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Menarini Overview List
TABLE ~ Products & Services List of Menarini
TABLE ~ Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Sanofi Overview List
TABLE ~ Products & Services List of Sanofi
TABLE ~ Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Ziopharm Oncology Overview List
TABLE ~ Products & Services List of Ziopharm Oncology
TABLE ~ Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Alchemia Overview List
TABLE ~ Products & Services List of Alchemia
TABLE ~ Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Amgen Overview List
TABLE ~ Products & Services List of Amgen
TABLE ~ Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Apotex Overview List
TABLE ~ Products & Services List of Apotex
TABLE ~ Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ BioMarin Pharmaceutical Overview List
TABLE ~ Products & Services List of BioMarin Pharmaceutical
TABLE ~ Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ CellAct Pharma Overview List
TABLE ~ Products & Services List of CellAct Pharma
TABLE ~ Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Cerulean Pharma Overview List
TABLE ~ Products & Services List of Cerulean Pharma
TABLE ~ Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Cipla Overview List
TABLE ~ Products & Services List of Cipla
TABLE ~ Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
TABLE ~ Cornerstone Pharmaceuticals Overview List
TABLE ~ Products & Services List of Cornerstone Pharmaceuticals
TABLE ~ Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
TABLE ~ Curis Overview List
TABLE ~ Products & Services List of Curis
TABLE ~ Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
TABLE ~ CytRx Overview List
TABLE ~ Products & Services List of CytRx
TABLE ~ Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
TABLE ~ Eli Lilly Overview List
TABLE ~ Products & Services List of Eli Lilly
TABLE ~ Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
TABLE ~ Exelixis Overview List
TABLE ~ Products & Services List of Exelixis
TABLE ~ Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
TABLE ~ Fresenius Kabi Overview List
TABLE ~ Products & Services List of Fresenius Kabi
TABLE ~ Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
TABLE ~ Genentech Overview List
TABLE ~ Products & Services List of Genentech
TABLE ~ Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
TABLE ~ Hikma Pharmaceuticals Overview List
TABLE ~ Products & Services List of Hikma Pharmaceuticals
TABLE ~ Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
TABLE ~ Hospira Overview List
TABLE ~ Products & Services List of Hospira
TABLE ~ Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
TABLE ~ Intas Pharmaceuticals Overview List
TABLE ~ Products & Services List of Intas Pharmaceuticals
TABLE ~ Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
TABLE ~ Karyopharm Therapeutics Overview List
TABLE ~ Products & Services List of Karyopharm Therapeutics
TABLE ~ Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
TABLE ~ Kyowa Hakko Kirin Overview List
TABLE ~ Products & Services List of Kyowa Hakko Kirin
TABLE ~ Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
TABLE ~ Ligand Pharmaceuticals Overview List
TABLE ~ Products & Services List of Ligand Pharmaceuticals
TABLE ~ Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales by Company 2016-2021E, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales by Company 2016-2021E, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share by Company 2016-2021E, in USD Million
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Share by Company 2016-2021E, in Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Sales Price by Company 2016-2021E, in USD/Volume
TABLE ~ Global Drugs for Non-small Cell Lung Cancer Gross Margin by Company 2016-2021E
TABLE ~ Major Companies Product Type List
TABLE ~ Major Companies Product Type List
TABLE ~ Mergers & Acquisitions in the Market